Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Expansion of the S–CN-DABO scaffold to exploit the impact on inhibitory activities against the non-nucleoside HIV-1 reverse transcriptase — Ling Xu (2022) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Expansion of the S–CN-DABO scaffold to exploit the impact on inhibitory activities against the non-nucleoside HIV-1 reverse transcriptase
Shared by
De Clercq Erik
KU Leuven
Expansion of the S–CN-DABO scaffold to exploit the impact on inhibitory activities against the non-nucleoside HIV-1 reverse transcriptase
Article
2022
en
Authors
+2 more
LX
Ling Xu
QH
Qingqing Hao
CP
Christophe Pannecouque
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2022
Expansion of the <i>S</i>-CN-DABO Scaffold to Exploit the Impact on Inhibitory Activities Against the Non-Nucleoside HIV-1 Reverse Transcriptase
Ling Xu
,
Qingqing Hao
,
Christophe Pannecouque
,
De Clercq Erik
,
Fen Er Chen
Article
2020
Scaffold Hopping in Discovery of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: From CH(CN)-DABOs to CH(CN)-DAPYs
Tingting Li
,
Christophe Pannecouque
,
De Clercq Erik
,
Chunlin Zhuang
,
Fen‐Er Chen
Article
2014
Synthesis and biological evaluation of new conformationally restricted S-DABO hybrids as non-nucleoside inhibitors of HIV-1 reverse transcriptase
Hai-Qiu Wu
,
Christophe Pannecouque
,
Zihong Yan
,
Wenxue Chen
,
Qiuqin He
,
Fen‐Er Chen
,
Jan Balzarini
,
Dirk Daelemans
,
De Clercq Erik
Article
2008
Non‐Nucleoside HIV‐1 Reverse‐Transcriptase Inhibitors. Part 10
Yueping Wang
,
Fen‐Er Chen
,
Jan Balzarini
,
De Clercq Erik
,
Christophe Pannecouque
Article
2009
Non‐Nucleoside HIV‐1 Reverse Transcriptase Inhibitors. Part 13
Yuan‐Zhen Xiong
,
Fen‐Er Chen
,
Jan Balzarini
,
De Clercq Erik
,
Christophe Pannecouque
Discussion(0)
No comments yet. Be the first to comment.